FierceBiotech 2026-01-12 Eikon next in line for IPO, with funds set to bankroll clutch of clinical cancer drugs
FierceBiotech 2026-01-12 'An undoing of the scientific method': Flagship CEO warns of government threats to US biotech industry
FierceBiotech 2026-01-12 Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health
FierceBiotech 2026-01-12 Quest Diagnostics highlights role of in vitro diagnostics in precision medicine
FierceBiotech 2026-01-09 AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
FierceBiotech 2026-01-09 Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech 2026-01-09 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Roche Media 2026-01-09 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
FierceBiotech 2026-01-09 Illumina hires former NHGRI Director Eric Green as new chief medical officer
FierceBiotech 2026-01-09 Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech 2026-01-09 Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
FierceBiotech 2026-01-08 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm